Pet22b-mEGFP Citations (2)
Originally described in: Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.Yu M, Peng Z, Qin M, Liu Y, Wang J, Zhang C, Lin J, Dong T, Wang L, Li S, Yang Y, Xu S, Guo W, Zhang X, Shi M, Peng H, Luo X, Zhang H, Zhang L, Li Y, Yang XP, Sun S Mol Cell. 2021 Feb 13. pii: S1097-2765(21)00010-1. doi: 10.1016/j.molcel.2021.01.010. PubMed Journal
Articles Citing Pet22b-mEGFP
| Articles |
|---|
| IL-37d enhances COP1-mediated C/EBPbeta degradation to suppress spontaneous neutrophil migration and tumor progression. Guo Y, Zhang Y, Guan Y, Chen N, Zhao M, Li Y, Zhou T, Zhang X, Zhu F, Guo C, Shi Y, Wang Q, Zhang L, Li Y. Cell Rep. 2024 Feb 27;43(2):113787. doi: 10.1016/j.celrep.2024.113787. Epub 2024 Feb 15. PubMed |
Probing condensate microenvironments with a micropeptide killswitch.
Zhang Y, Stoppelkamp I, Fernandez-Pernas P, Allram M, Charman M, Magalhaes AP, Piedavent-Salomon M, Sommer G, Sung YC, Meyer K, Grams N, Halko E, Dongre S, Meierhofer D, Malszycki M, Ilik IA, Aktas T, Kraushar ML, Vastenhouw N, Weitzman MD, Grebien F, Niskanen H, Hnisz D.
Nature. 2025 Jun 4. doi: 10.1038/s41586-025-09141-5.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.